Salome L. Roux
Grabels, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A new in vitro rat liver platform capturing biological diversity for drug-induced liver injury assessment and reduction of animal use in drug discovery and development.
Journal: Frontiers in toxicology
Published: January 09, 2026
Divergent Roles of mGlu2 and mGlu3 Receptors in Amyloid-β Production and Cognitive Dysfunctions in Alzheimer's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 21, 2025
AI-enhanced clinical trial-in-a-dish platform for improved DILI risk classification and mechanistic insights into hepatotoxicity.
Journal: Frontiers in toxicology
Published: November 06, 2025
A serum-derived 3D tumor model platform for personalized prediction and monitoring of chemotherapeutic response in pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: October 01, 2025
Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy.
Journal: Scientific reports
Published: October 10, 2024
Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone.
Journal: Frontiers in pharmacology
Published: January 29, 2024
Soluble amyloid-β precursor peptide does not regulate GABAB receptor activity.
Journal: eLife
Published: July 21, 2022
Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain.
Journal: Nature chemical biology
Published: November 12, 2021
Interface bonding in silicon oxide nanocontacts: interaction potentials and force measurements.
Journal: Nanotechnology
Published: February 07, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026